)
Edge17 Oct 2025
A Castle in the Sky: The Story of Oracle
Oracle's journey from database innovator to disciplined enterprise backbone, now shaping the AI buildout with a standardized cloud infrastructure.
Assertio (ASRT) investor relations material
Assertio Q2 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q2 2025 earnings summary11 Aug, 2025
Executive summary
Q2 2025 net product sales were $28.8M, down from $30.7M year-over-year, with strong demand for Rolvedon and Sympazan, and Indocin performing as expected amid generic competition.
Net loss for Q2 2025 was $16.4M, driven by lower sales, legal expenses, and one-time charges from divestitures and portfolio changes.
Transformation strategy advanced through legal settlements, corporate simplification, and divestment of Assertio Therapeutics, eliminating opioid litigation exposure.
Ceased commercialization of Otrexup, incurring $3.8M in related expenses and narrowing revenue outlook.
Cash and investments rose to $98.2M at quarter-end, supporting future strategic moves.
Financial highlights
Q2 2025 net product sales: $28.8M (down from $30.7M Q2 2024); six months: $54.8M (down from $62.6M 2024).
Rolvedon sales: $16.1M (up from $15.1M), Sympazan: $3.2M (up from $2.7M), Indocin: $3.0M (down from $6.9M).
Q2 2025 net loss: $(16.4)M (vs. $(3.7)M Q2 2024); six months: $(29.9)M (vs. $(8.2)M 2024).
Adjusted EBITDA for Q2 2025: $5.6M (up from $3.1M Q2 2024); six months: $5.9M (down from $10.4M 2024).
SG&A expenses decreased to $17.0M, aided by a $2.4M employee retention tax credit.
Outlook and guidance
Full-year 2025 net product sales guidance narrowed to $108M–$118M.
Adjusted EBITDA guidance raised to $11M–$19M, reflecting cost savings and operational efficiencies.
Guidance reflects first-half performance, Otrexup discontinuation, and improved cost structure.
Expectation to further narrow guidance after Q3.
Management believes existing liquidity is sufficient for at least the next 12 months, barring significant unforeseen events.
Explain the impact of generic Indocin competition.
Assess the impact of Otrexup's decommercialization.
What is driving Sympazan's new prescription growth?
Rolvedon Q2 true sales figure
Otrexup halt: SG&A savings impact?
Strategic transaction market conditions
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Assertio earnings date
Q3 202510 Nov, 2025
The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
Company Research17 Oct 2025
Beneath the Surface: A Conversation with Epiroc CEO Helena Hedblom
Legacy, innovation, and leading one of Sweden's most influential industrial companies into a new era.
)
Investor Relations14 Oct 2025
Boost Your Earnings Season Strategy With Real‑Time Alerts
Quartr Pro provides real time alerts, trend analysis and live coverage, giving analysts and investors instant insights to act faster in earnings.
Frequently asked questions
Assertio Holdings Inc. is a pharmaceutical company focused on the development, marketing, and distribution of prescription medications. The company specializes in providing treatments for patients with chronic pain, neurological disorders, and other medical conditions. Assertio's portfolio includes a range of therapies aimed at improving patient quality of life, with an emphasis on non-opioid options for pain management. The company is headquartered in Lake Forest, Illinois, and its shares are listed on the NASDAQ.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage